Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection

Journal of Clinical Investigation

Volumn 104, Issue 12, 1999, Pages 1715-1722

  Trambley, Joel ^a   Bingaman, Adam W ^a   Lin, Angello ^a   Elwood, Eric T ^a   Waitze, Seung Yeun ^a   Ha, Jongwon ^a   Durham, Megan M ^a   Corbascio, Matthias ^b   Cowan, Shannon R ^a   Pearson, Thomas C ^a   Larsen, Christian P ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GANGLIOTETRAOSYLCERAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033379266     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8082     Document Type: Article

References (50)

1. Pearson, T., Darby, C.R., Bushell, A.R., Morris, P.J., and Wood, K.J. 1993. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation. 55:361-367.
2. Qin, S., et al. 1993. "Infectious" transplantation tolerance. Science. 259:974-977.
3. Wood, K.J., Pearson, T.C., Darby, C., and Morris, P.J. 1991. CD4: a potential target molecule for immunosuppressive therapy and tolerance induction. Transplant. Rev. 5:150-164.
4. Krieger, N.R., Yin, D.P., and Fathman, C.G. 1996. CD4+ but not CD8+ cells are essential for allorejection. J. Exp. Med. 184:2013-2018.
5. Young, J.W., and Steinman, R.M. 1990. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper cells. J. Exp. Med. 171:1315-1332.
6. Inaba, K., Young, J.W., and Steinman, R.M. 1987. Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-194.
7. Hall, B.M. 1991. Cells mediating allograft rejection. Transplantation. 51:1141-1151.
8. Grewal, I.S., Xu, J., and Flavell, R.A. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:617-620.
9. van Essen, D., Kikutani, H., and Gray, D. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378:620-623.
10. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
11. Jenkins, M.K., Taylor, P.S., Norton, S.D., and Urdahl, K.B. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461-2466.
12. Kirk, A.D., et al. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94:8789-8794.
13. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
14. Elwood, E.T., et al. 1998. Prolonged acceptance of skin and cardiac xenografts with combined CD40 and CD28 pathway blockade. Transplantation. 65:1422-1428.
15. Bolton, E.M., Gracie, J.A., Briggs, J.D., Kampinga, J., and Bradley, J.A. 1989. Cellular requirements for renal allograft rejection in the athymic nude rat. J. Exp. Med. 169:1931-1946.
16. Dallman, M.J., and Mason, D.W. 1982. Role of thymus-derived and thymus-independent cells in murine skin allograft rejection. Transplantation. 33:221-223.
17. Van Buskirk, A.M., Wakely, M.E., and Orosz, C.G. 1996. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations. Transplantation. 62:300-302.
18. Ohlen, C., et al. 1989. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science. 246:666-668.
19. Lee, L.A, Sergio, J.J., and Sykes, M. 1996. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation. 61:125-132.
20. Gritsch, H.A., et al. 1994. The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation. 57:906-917.
21. Zhao, Y., et al. 1996. Skin graft tolerance across a discordant xenogeneic barrier. Nat. Med. 2:1211-1216.
22. Petersson, E., et al. 1997. Allogeneic heart transplantation activates alloreactive NK cells. Cell. Immunol. 175:25-32.
23. Kasai, M., Iwamori, M., Nagai, Y., Okumura, K., and Tada, T. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:175-180.
24. Zhao, Y., et al. 1996. Skin graft tolerance across a discordant xenogeneic barrier. Nat. Med. 2:1211-1216.
25. Skeen, M.J., and Ziegler, H.K. 1993. Induction of murine peritoneal gamma/delta T cells and their role in resistance to bacterial infection. J. Exp. Med. 178:971-984.
26. Song, U.K., et al. 1999. Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J. Immunol. 162:2467-2471.
27. Kurts, C., Kosaka, H., Carbone, F.R., Miller, J.F., and Heath, W.R. 1997. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autorcactive CD8(+) T cells. J. Exp. Med. 186:239-245.
28. Wells, A.D., Gudmundsdottir, H., and Turka, L.A. 1997. Following the face of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173-3183.
29. Newell, K.A., et al. 1999. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J. Immunol. 163:2358-2362.
30. Sfikakis, P.P., et al. 1995. CD28 expression on T cell subsets in vivo and CD28-mediated T cell response in vitro in patients with rheumatoid arthritis. Arthritis Rheum. 38:649-654.
31. Kasiske, B.L., et al. 1991. The effect of race on access and outcome in transplantation [see comments]. N. Engl. J. Med. 324:302-307.
32. Lee, U., Santa, K., Habu, S., and Nishimura, T. 1996. Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors. Jpn. J. Cancer Res. 87:429-432.
33. Ting, C.C., Hargrove, M.E., Wunderlich, J., and Loh, N.N. 1987. Differencial expression of asialo GM1 on alloreactive cytotoxic T lymphocytes and lymphokine-activated killer cells. Cell. Immunol. 104:115-125.
34. Charley, M.R., Mikhael, A., Hackett, J., Kumar, V., and Bennert, M. 1988. Mechanism of anti-asialo GM1 prevention of graft-vs-host disease: identification of allo-antigen activated T cells. J. Invest. Dermatol. 91:202-206.
35. Stout, R.D., Schwarting, G.A., and Suttles, J. 1987. Evidence that expression of asialo-GM1 may be associated with cell activation. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J. Immunol. 139:2123-2129.
36. Stout, R.D., and Suttles, J. 1992. T cells bearing the CD44hi "memory" phenotype display characteristics of activated cells in G1 stage of cell cycle. Cell. Immunol. 141:433-443.
37. Ting, C.C., Bluestone, J.A., Hargrove, M.E., and Loh, N.N. 1986. Expression and function of asialo GM1 in alloreactive cytotoxic T lymphocytes. J. Immunol. 137:2100-2106.
38. Grewal, I.S., et al. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1864-1867.
39. Early, G.S., Zhao, W., and Burns, C.M. 1996. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black × New Zealand white mice. Response correlates with the absence of an anti-antibody response. J. Immunol. 157:3159-3164.
40. Campbell, K.A., et al. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
41. Whitmire, J.K., Slifka, M.K., Grewal, I.S.,Flavell, R.A., and Ahmed, R. 1996. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection [published erratum appears in J. Virol. 1997;71:1736]. J. Virol. 70:8375-8381.
42. Shahinian, A., et al. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:609-612.
43. Ridge, J.P., Di Rosa, F., and Matzinger, P. 1998. A conditioned dendritic cell can be a temporal bridge between CD4+ T-helper and a T-killer cell. Nature. 393:474-478.
44. Bennett, S.R.M., et al. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:478-480.
45. Schoenberger, S.P., Toes, R.E.M., van der Voort, E.I.H., Offringa, R., and Melief, C.J.M. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-Cn40L interactions. Nature. 393:480-483.
46. Shuford, W.W., et al. 1997. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47-55.
47. Suzuki, I., and Fink, P.J. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187:123-128.
48. DeBenedette, M.A., Shahinian, A., Mak, T.W., and Watts, T.H. 1997. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158:551-559.
49. Luxembourg, A.T., et al. 1998. Requirements for stimulating naive CD8+ T cells via signal 1 alone. J. Immunol. 161:5226-5235.
50. Goldstein, J.S., Chen, T., Brunswick, M., Mostowsky, H., and Kozlowski, S. 1998. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions. J. Immunol. 160:3180-3187.